Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Hydra Biosciences brings in $9.3mm in first round

Executive Summary

Hydra Biosciences, specializing in molecular regeneration medicines, raised $9.3mm in a Series A private placement. Polaris Venture Partners led the financing with Abingworth Management Ltd. as co-lead. Other investors included New Enterprise Associates, Advanced Technology Ventures, and Boston Medical Investors.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register